Proinflammatory Effects of Calprotectin in Graves' Orbitopathy.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Works by Ko, JaeSang
Results: 19
1
2
Therapeutic role of histone deacetylase inhibition in an in vitro model of Graves' orbitopathy.
- Published in:
- Molecular Medicine Reports, 2024, v. 30, n. 6, p. N.PAG, doi. 10.3892/mmr.2024.13342
- By:
- Publication type:
- Article
3
Therapeutic effect of ibrutinib, a selective Bruton's tyrosine kinase inhibitor, in orbital fibroblasts from patients with Graves' orbitopathy.
- Published in:
- PLoS ONE, 2022, v. 17, n. 12, p. 1, doi. 10.1371/journal.pone.0279060
- By:
- Publication type:
- Article
4
Surgical outcomes of lamellar macular holes with and without lamellar hole-associated epiretinal proliferation.
- Published in:
- Acta Ophthalmologica (1755375X), 2017, v. 95, n. 3, p. e221, doi. 10.1111/aos.13245
- By:
- Publication type:
- Article
5
Protein tyrosine phosphatase 1B as a therapeutic target for Graves' orbitopathy in an in vitro model.
- Published in:
- PLoS ONE, 2020, v. 14, n. 8, p. 1, doi. 10.1371/journal.pone.0237015
- By:
- Publication type:
- Article
6
Therapeutic effect of nintedanib in orbital fibroblasts in patients with Graves' orbitopathy.
- Published in:
- Immunopharmacology & Immunotoxicology, 2025, v. 47, n. 3, p. 406, doi. 10.1080/08923973.2025.2491554
- By:
- Publication type:
- Article
7
Therapeutic role of physalin A in the pathogenesis of Graves' orbitopathy.
- Published in:
- Immunopharmacology & Immunotoxicology, 2024, v. 46, n. 6, p. 912, doi. 10.1080/08923973.2024.2422079
- By:
- Publication type:
- Article
8
Sarcopenia as a potential risk factor for senile blepharoptosis: Nationwide Surveys (KNHANES 2008–2011).
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-31097-7
- By:
- Publication type:
- Article
9
Albuminuria Is Associated with Open-Angle Glaucoma in Nondiabetic Korean Subjects: A Cross-Sectional Study.
- Published in:
- PLoS ONE, 2016, v. 11, n. 12, p. 1, doi. 10.1371/journal.pone.0168682
- By:
- Publication type:
- Article
10
Semi-automated fabrication of customized ocular prosthesis with three–dimensional printing and sublimation transfer printing technology.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. 1, doi. 10.1038/s41598-019-38992-y
- By:
- Publication type:
- Article
11
Anti-oxidative and anti-adipogenic effects of caffeine in an in vitro model of Graves' orbitopathy.
- Published in:
- Endocrine Journal, 2020, v. 67, n. 4, p. 439, doi. 10.1507/endocrj.ej19-0521
- By:
- Publication type:
- Article
12
Endoscopic transorbital approach to the cavernous sinus: Cadaveric anatomy study and clinical application (SevEN-009).
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.962598
- By:
- Publication type:
- Article
13
Yes-Associated Protein Mediates the Transition from Inflammation to Fibrosis in Graves' Orbitopathy.
- Published in:
- Thyroid, 2023, v. 33, n. 12, p. 1465, doi. 10.1089/thy.2023.0309
- By:
- Publication type:
- Article
14
Role of Proprotein Convertase Subtilisin/Kexin Type 9 in the Pathogenesis of Graves' Orbitopathy in Orbital Fibroblasts.
- Published in:
- Frontiers in Endocrinology, 2021, v. 11, p. N.PAG, doi. 10.3389/fendo.2020.607144
- By:
- Publication type:
- Article
15
Tumor necrosis factor-like weak inducer of apoptosis induces inflammation in Graves’ orbital fibroblasts.
- Published in:
- PLoS ONE, 2018, v. 13, n. 12, p. 1, doi. 10.1371/journal.pone.0209583
- By:
- Publication type:
- Article
16
Role of Inositol-Requiring Enzyme 1 and Autophagy in the Pro-Fibrotic Mechanism Underlying Graves' Orbitopathy.
- Published in:
- Yonsei Medical Journal, 2024, v. 65, n. 7, p. 397, doi. 10.3349/ymj.2023.0294
- By:
- Publication type:
- Article
17
Congenital Orbital Fibrosis: Molecular Genetic Analysis by Whole-Exome and Mitochondrial Genome Sequencing.
- Published in:
- Yonsei Medical Journal, 2017, v. 58, n. 5, p. 1078, doi. 10.3349/ymj.2017.58.5.1078
- By:
- Publication type:
- Article
18
Quantitative assessment of increase in orbital volume after orbital floor fracture reconstruction using a bioabsorbable implant.
- Published in:
- Graefe's Archive of Clinical & Experimental Ophthalmology, 2022, v. 260, n. 9, p. 3027, doi. 10.1007/s00417-022-05610-z
- By:
- Publication type:
- Article
19
Compound C exerts a therapeutic effect on Graves' orbitopathy via AMPK‑independent pathways.
- Published in:
- International Journal of Molecular Medicine, 2025, v. 55, n. 5, p. N.PAG, doi. 10.3892/ijmm.2025.5524
- By:
- Publication type:
- Article